Are additional localization studies and referral indicated for patients with primary hyperparathyroidism who have negative sestamibi scan results?

Archives of Surgery

Volumn 145, Issue 6, 2010, Pages 578-581

  Elaraj, Dina M ^a   Sippel, Rebecca S ^b   Lindsay, Sheila ^b   Sansano, Ileana ^b   Duh, Quan Yang ^b   Clark, Orlo H ^b   Kebebew, Electron ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOPHARMACEUTICAL AGENT; SESTAMIBI; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; ECTOPIC THYROID GLAND; FEMALE; HUMAN; HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL;

ADULT; AGED; DIAGNOSTIC IMAGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; PARATHYROID GLANDS; PARATHYROID HORMONE; PARATHYROIDECTOMY; PATIENT SELECTION; PREOPERATIVE CARE; PROBABILITY; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TECHNETIUM TC 99M SESTAMIBI; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER;

EID: 77953837817     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2010.108     Document Type: Article

References (18)

1. Kebebew E, Clark OH. Parathyroid adenoma, hyperplasia, and carcinoma: localization, technical details of primary neck exploration, and treatment of hypercalcemic crisis. Surg Oncol Clin N Am. 1998;7(4):721-748. (Pubitemid 28436537)
2. Uruno T, Kebebew E. How to localize parathyroid tumors in primary hyperparathyroidism? J Endocrinol Invest. 2006;29(9):840-847. (Pubitemid 44869431)
3. Palazzo FF, Delbridge LW. Minimal-access/minimally invasive parathyroidectomy for primary hyperparathyroidism. Surg Clin North Am. 2004;84(3):717-734.
4. Civelek AC, Ozalp E, Donovan P, Udelsman R. Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery. 2002;131(2):149-157.
5. Sebag F, Hubbard JG, Maweja S, Misso C, Tardivet L, Henry JF. Negative preoperative localization studies are highly predictive of multiglandular disease in sporadic primary hyperparathyroidism. Surgery. 2003;134(6):1038-1042.
6. Mihai R, Gleeson F, Buley ID, Roskell DE, Sadler GP. Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients. World J Surg. 2006;30(5):697-704.
7. Yip L, Pryma DA, Yim JH, Carty SE, Ogilvie JB. Sestamibi SPECT intensity scoring system in sporadic primary hyperparathyroidism. World J Surg. 2009;33(3):426-433.
8. Harari A, Zarnegar R, Lee J, Kazam E, Inabnet WB III, Fahey TJ III. Computed tomography can guide focused exploration in select patients with primary hyperparathyroidism and negative sestamibi scanning. Surgery. 2008;144(6):970-979.
9. Davis ML, Quayle FJ, Middleton WD, et al. Ultrasound facilitates minimally invasive parathyroidectomy in patients lacking definitive localization from preoperative sestamibi scan. Am J Surg. 2007;194(6):785-791.
10. Chan RK, Ruan DT, Gawande AA, Moore FD Jr. Surgery for hyperparathyroidism in image-negative patients. Arch Surg. 2008;143(4):335-337.
11. Gawande AA, Monchik JM, Abbruzzese TA, Iannuccilli JD, Ibrahim SI, Moore FD Jr. Reassessment of parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism after 2 preoperative localization studies. Arch Surg. 2006;141(4):381-384.
12. Arici C, Cheah WK, Ituarte PH, et al. Can localization studies be used to direct focused parathyroid operations? Surgery. 2001;129(6):720-729.
13. Ruda JM, Stack BC Jr, Hollenbeak CS. The cost-effectiveness of additional preoperative ultrasonography or sestamibi-SPECT in patients with primary hyperparathyroidism and negative findings on sestamibi scans. Arch Otolaryngol Head Neck Surg. 2006;132(1):46-53.
14. Phitayakorn R, McHenry CR. Incidence and location of ectopic abnormal parathyroid glands. Am J Surg. 2006;191(3):418-423.
15. Mozzon M, Mortier PE, Jacob PM, Soudan B, Boersma AA, Proye CA. Surgical management of primary hyperparathyroidism: the case for giving up quick intraoperative PTH assay in favor of routine PTH measurement the morning after. Ann Surg. 2004;240(6):949-954.
16. Kebebew E, Hwang J, Reiff E, Duh QY, Clark OH. Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model. Arch Surg. 2006;141(8):777-782.
17. Sosa JA, Tuggle CT, Wang TS, et al. Clinical and economic outcomes of thyroid and parathyroid surgery in children. J Clin Endocrinol Metab. 2008;93(8):3058-3065.
18. Sosa JA, Powe NR, Levine MA, Udelsman R, Zeiger MA. Profile of a clinical practice: thresholds for surgery and surgical outcomes for patients with primary hyperparathyroidism: a national survey of endocrine surgeons. J Clin Endocrinol Metab. 1998;83(8):2658-2665.